HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Galderma Canada

This article was originally published in The Rose Sheet

Executive Summary

Galderma Canada: Dermatologics company finalizes acquisition of a 13,500 square-meter manufacturing facility in Baie d'Urfe, Quebec, the Mississauga, Ontario-based Galderma subsidiary announced May 6. The new facility will service the U.S., Canada, Mexico, Puerto Rico, Central American and Caribbean markets by distributing the company's dermatological products to wholesalers and pharmacies. Galderma, which is jointly owned by L'Oreal and Nestle, has earmarked about $25.6 mil. ($35 mil. Canadian) to the plant for purchasing, upgrading and installing new equipment based on a May 6 exchange rate of $1 = 1.3652 CDN, the firm said. The company expects the plant to be fully operational by the first quarter of 1998, with the capacity to "produce 40 million units for 70 product forms," the firm said. Galderma manufactures Differin anti-acne treatment and Cetaphil skin cleanser...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel